Click on one of these terms to refine your search
1 to 2 of 2 literature results
OBJECTIVE: Cardiovascular disease (CVD) risk is increased in type 2 diabetes. The purpose of this study was to assess the effect of 10 mg of atorvasta…
Authors: Robert H Knopp, Michael d'Emden, Johan G Smilde, Stuart J Pocock
Source: Diabetes care. 2006 Jul
View Full TextOBJECTIVE: We explored whether cardiovascular disease (CVD) risk and the effects of fenofibrate differed in subjects with and without metabolic syndro…
Authors: Russell Scott, Richard O'Brien, Greg Fulcher, Chris Pardy, Michael D'Emden, Dana Tse, Marja-Riitta Taskinen, Christian Ehnholm, Anthony Keech, Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators
Source: Diabetes care. 2009 Mar
View Free Full Text